Indefinite Delivery Contract 75N93024D00003
Award Date
9/30/24
Last Date to Order
9/29/31
Federal Agency
National Institute of Allergy and Infectious Diseases
Awardee
Duke University
Ultimate Awardee
Not listed
NAICS Category
541715 - Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Federal Contract Vehicle
Pricing Type
Cost No Fee
Legislative Mandate
Employment Eligibility Verification
National Interest Action
None
Award Type
Single
Primary Consortia Member
Not listed
Similar IDVs
The National Institute of Allergy and Infectious Diseases (NIAID), part of the Department of Health and Human Services, awarded an indefinite-delivery/indefinite-quantity (IDIQ) contract to Duke University's Office of Research Administration Division to support Phase 0 through Phase II clinical trials of investigational products against infectious diseases. The IDIQ contract, valued at up to $346,610,277, has a performance period from January 14, 2022 to January 13, 2032. Under this IDIQ, Duke...
The federal contract IDV award, with an ID of 75N93024D00022, was issued by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency under the Department of Health and Human Services (HHS). This single-award Indefinite Delivery Contract, potentially valued up to $146,300,000, is for pre-clinical models of infectious diseases under task areas A, B, and C. The prime contractor, Texas Biomedical Research Institute, will provide a range of services including developing...
This Indefinite Delivery Contract (IDC) was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the U.S. Department of Health and Human Services, to Duke University's Office of Research Administration Division as the prime contractor. The $20,000,000 IDC falls under the NIAID Animal Models of Infectious Diseases 2010-2017 multiple-award IDIQ contract vehicle and does not have any set-aside designations. Under this IDC, Duke University will...
The National Institute of Allergy and Infectious Diseases awarded an indefinite delivery contract to The Emmes Company LLC on September 1, 2021. With a potential value of $545,452,906 over seven years, this single award IDC supports NIAID's research programs through a broad range of services. Task Order 1 issued under the contract is a firm fixed price order valued at $2,000 to satisfy minimum requirements. Performance will take place in Potomac, MD from September 1, 2021 through August 31,...
This indefinite delivery contract (IDC) was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, to Bioqual, Inc., a for-profit biomedical research services company, to support the Simian Vaccine Evaluation Units (SVEU) program. The $66,355,351.00 IDC, which has an ultimate completion date of March 31, 2027, provides a vehicle for NIAID to issue delivery orders to Bioqual for conducting specialized research studies, providing laboratory analysis, and...
This Indefinite Delivery Contract (IDC) was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency under the Department of Health and Human Services, to Emory University, a private research university. The contract has a ceiling value of $146,300,000 and a period of performance through July 2031. The purpose of this IDC is to provide NIAID with the capability to develop, refine, and employ small animal models, non-human primate models, animal...
The federal contract IDV award, with ID 266985346, is an Indefinite Delivery Contract (IDC) awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the U.S. Department of Health and Human Services. The contract, with a ceiling value of $1,034,379, is for MALARIAL CLINICAL RESEARCH & TRIAL PREPARATION SITES and was awarded to the University System of Maryland on July 15, 2001. The contract includes a single task order, with award ID...
The National Institute of Allergy and Infectious Diseases (NIAID), part of the U.S. Department of Health and Human Services, awarded this $107,274,471 Indefinite Delivery/Indefinite Quantity (IDIQ) contract to the University of North Carolina at Chapel Hill (UNC-CH) to provide preclinical development support for candidate products and drug development activities related to infectious diseases like HIV, hepatitis, and tuberculosis. The contract encompasses a wide range of services including in...
This indefinite delivery contract (IDC) was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the Department of Health and Human Services, to the American Foundation For Biological Research, doing business as the Biomedical Research Institute. The $146.3 million single-award IDC has a period of performance from July 15, 2024 to July 14, 2031. The purpose of this IDC is to provide NIAID with the capability and capacity to develop and employ...
The federal contract IDV award is for the National Institute of Allergy and Infectious Diseases' (NIAID) Early Phase Clinical Trial Units (EPCTU) program. The $346.6 million, multiple-award IDIQ contract was awarded to Icon Government And Public Health Solutions, Inc., a foreign-owned, for-profit organization that specializes in providing comprehensive clinical research services to federal agencies, particularly in the areas of medical countermeasure development and public health emergency...
Name | Description | Awardee | Potential Value (Click to sort descending) | Award Date (Click to sort descending) | Completion Date (Click to sort descending) | Updated At (Click to sort descending) |
|---|---|---|---|---|---|---|
Delivery Order 75N93024D00003-75N93024F00001 | Duke University | $34.2m | 9/30/24 | 9/29/31 | 9/5/24 |